Wuppertal, Germany

Axel Durkop

This inventor holds 1 USPTO granted patent. Top assignee: Active Motif Chromeon Gmbh. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Axel Durkop. Retrieved from https://idiyas.com/inventor/axel-durkop

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 159(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Axel Durkop

Introduction

Axel Durkop is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of bioanalytical methods, particularly through his innovative patent.

Latest Patents

Durkop holds a patent for a bioanalytical measuring method that utilizes oxidases and lanthanoid-ligand complexes. This invention focuses on biological determination methods that employ enzymes from the oxidase group and optical indicators derived from lanthanoid-ligand complexes. His work represents a significant advancement in the field of bioanalysis.

Career Highlights

Durkop is associated with Active Motif Chromeon GmbH, where he applies his expertise in bioanalytical methods. His career reflects a commitment to advancing scientific knowledge and practical applications in biotechnology.

Collaborations

One of his notable collaborators is Otto S Wolfbeis, with whom he has worked on various projects related to bioanalytical methods.

Conclusion

Axel Durkop's contributions to bioanalytical methods through his patent highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the field and pave the way for future developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…